BPR (Biocidal Products Regulation)

The Biocidal Products Regulation (BPR), enforced under Regulation (EU) No 528/2012, governs the placing on the market and use of biocidal products and treated articles within the European Union ¹. Biocidal products are used to protect humans, animals, materials, or articles against harmful organisms like pests or bacteria, through the action of active substances ².

In consumer goods manufacturing, items such as anti-odor athletic apparel, anti-bacterial kitchen cutting boards, mold-resistant shoe insoles, and anti-dust-mite bedding are classified as Treated Articles under Article 58 of the BPR, requiring strict regulatory compliance prior to EU distribution³.

What Defines a "Treated Article" Under EU BPR?

ATreated Articleis defined as any substance, mixture, or article which has been treated with, or intentionally incorporates, one or more biocidal products ¹:

• Internal / External Treatment: Examples include plastic handles molded with silver-ion anti-bacterial masterbatch, or outdoor furniture cushions treated with fungal inhibitors.
• Primary Biocidal Function vs. Treated Article: If an article's primary function is biocidal (e.g., disinfectant wipes or insecticidal nets), it is regulated as a standalone Biocidal Product, requiring comprehensive prior product authorization rather than simple treated article status ².

Active Substance Approval Requirements

Under Article 58(2) of Regulation (EU) No 528/2012, a treated article cannot be placed on the EU market unless all active substances contained in the biocidal product are approved¹:

• Union List of Active Substances: Active substances must be formally approved (or under active evaluation in the Review Programme) for the specific Product-Type (PT) corresponding to the application³.
• Relevant Product-Types (PT):PT 2: Disinfectants and algaecides not intended for direct application to humans or animals.PT 7: Film preservatives (protecting surface coatings or paints against micro-organisms).PT 9: Fibre, leather, rubber, and polymerised materials preservatives (protecting plastics, rubber, and textiles).

Mandatory Labeling Requirements for Treated Articles

If a manufacturer or importer makes a biocidal claim regarding the product (e.g., "Anti-bacterial protection", "Odors caused by bacteria eliminated", "Anti-mold treated"), or where active substance approval conditions mandate it, the product packaging must display a BPR-compliant label containing¹:

1. Clear Explicit Statement: A statement that the article incorporates biocidal products (e.g., "This item contains a biocidal product to control odors").
2. Biocidal Property Claim: The specific biocidal property attributed to the treated article (e.g., "Inhibits bacterial growth").
3. Name of Active Substances: The exact chemical name of all active substances (e.g., "Active substance: Silver phosphate glass" or "Zinc pyrithione").
4. Relevant Nanomaterials: Inclusion of any nanomaterials, explicitly followed by the word 'nano' in brackets (e.g., "Silver nanoparticles (nano)").
5. Precautionary Instructions: Necessary instructions for use and safety precautions to protect humans and the environment.

Practical Module: On-Site BPR Verification & Chemical QC Practice

To ensure that anti-bacterial or anti-mold treatments applied in factories conform to EU BPR and US EPA regulations without causing shipment rejections, QC inspectors should enforce the following operational steps:

Step 1: Active Substance List (ASL) and Supplier Bill of Chemicals Audit

• Request the chemical supplier's Technical Data Sheet (TDS) and Safety Data Sheet (SDS) for any anti-bacterial or anti-mold chemical additives used in production.
• Cross-check the active substance CAS number directly on the ECHA Biocidal Active Substances Database to verify that the substance is approved for the correct Product-Type (e.g., PT 9 for textiles/plastics).

Step 2: Verification of Packaging Biocidal Claims

• Review all master carton printing, polybag art, hangtags, and user manuals during a Pre-Shipment Inspection (PSI).
• Ensure marketing text does not make unapproved medical or health claims (e.g., "Prevents viral infections" or "Kills 99.9% of disease-causing germs"), which immediately triggers re-classification from a simple treated article to a restricted medical device or unauthorized pesticide.

Step 3: Quantitative Antibacterial Efficacy Spot Testing

• Draw random production samples from the factory floor and send them to an ISO 17025 accredited microbiology laboratory.
• Execute standardized microbiological efficacy tests according to international protocols:AATCC 100 / ISO 20743: Quantitative antibacterial assessment on textile materials.JIS Z 2801 / ISO 22196: Antibacterial activity assessment on non-porous plastic and hard surfaces.ASTM G21: Standard practice for determining resistance of synthetic polymeric materials to fungi/mold.

References

[1] European Parliament and Council. Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products (BPR)[S]. Brussels: Official Journal of the European Union, 2012.

[2] European Chemicals Agency. Guidance on Treated Articles under Regulation (EU) No 528/2012[R]. Helsinki: ECHA, 2023.

[3] U.S. Environmental Protection Agency. Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide Registration Notice 2000-1: Consumer Products Treated with Pesticides[R]. Washington D.C.: EPA, 2000.

Reference Notes

1. Regulation (EU) No 528/2012 (BPR) is the primary European Union statute defining approval rules for active substances, biocidal products, and treated article labeling mandates.
2. ECHA Guidance on Treated Articles provides official legal interpretations distinguishing treated articles from biocidal products and specifying label formatting standards.
3. US EPA PR Notice 2000-1 outlines equivalent US Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) treated article exemption criteria for comparison against EU BPR standards.